Search Results - "Hendricksen K"

Prospective clinical study of sentinel node detection in bladder cancer using a hybrid tracer – Towards replacement of pelvic lymph node dissection in cases with sentinel node visualization on SPECT/CT?

Authors: van Gennep, E. J. Pisano, G. KleinJan, G. H. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Aug2025, Vol. 52 Issue 10, p3653-3661. 9p.

The orthotopic Fischer/AY-27 rat bladder urothelial cell carcinoma model to test the efficacy of different apaziquone formulations.

Authors: Arentsen HC Hendricksen K Hulsbergen-van de Kaa CA et al.

Source: Urologic Oncology. Jan2012, Vol. 30 Issue 1, p64-68. 5p.

False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression?

Authors: Hendricksen, K. Moonen, P. Heijden, A. et al.

Source: World Journal of Urology. Oct2006, Vol. 24 Issue 5, p597-601. 5p. 4 Charts.

Photographic assessment of urostomy characteristics after ileal conduit diversion: a feasibility study.

Authors: Posthumus, Joëlle M. van de Kamp, M. W. Fransen, L. et al.

Source: World Journal of Urology. 6/26/2026, Vol. 44 Issue 1, p1-7. 7p.

Prediction of early (30-day) and late (30–90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades.

Authors: Korbee, M. L. Voskuilen, C. S. Hendricksen, K. et al.

Source: World Journal of Urology. Sep2020, Vol. 38 Issue 9, p2197-2205. 9p.

311 THE ORTHOTO PIC FISCHER/AY-27 RAT BLADDER UROTHELIAL CELL CARCINOMA MODEL TO TEST THE EFFICACY OF DIFERENT EOQUIN™ FORMULATIONS

Authors: Arentsen, H.C. Hendricksen, K. Hulsbergen-Van De Kaa, C.A. et al.

Source: European Urology Supplements. Mar2009, Vol. 8 Issue 4, p198-198. 1p.

554 EVALUATION OF AN ORTHOTOPIC RAT BLADDER UROTHELIAL CELL CARCINOMA MODEL BY CYSTOSCOPY

Authors: Hendricksen, K. Molkenboer-Kuenen, J. Oosterwijk, E. et al.

Source: European Urology Supplements. Mar2008, Vol. 7 Issue 3, p209-209. 1p.

150 INTRAVESICAL HYPERTHERMIA AND MITOMYCIN-C FOR (BCG REFRACTORY) CARCINOMA IN SITU OF THE URINARY BLADDER

Authors: Witjes, J.A. Hendricksen, K. Gofrit, O. et al.

Source: European Urology Supplements. Feb2007, Vol. 6 Issue 2, p60-60. 1p.

149 THREE SCHEDULES OF ADJUVANT INTRAVESICAL EPIRUBICIN IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER: A COMPARATIVE STUDY

Authors: Hendricksen, K. Kiemeney, L.A. Caris, C. et al.

Source: European Urology Supplements. Feb2007, Vol. 6 Issue 2, p60-60. 1p.

10 VALIDATION OF THE EORTC RECURRENCE SCORE BY THE USE OF AN ADJUVANT INTRAVESICAL EPIRUBICIN STUDY

Authors: Hendricksen, K. Kiemeney, L.A. Caris, C. et al.

Source: European Urology Supplements. Feb2007, Vol. 6 Issue 2, p25-25. 1p.

UP-03.44: False-positive lesions detected by fluorescence cystoscopy: A clue to early malignancy?

Authors: Hendricksen, K. Moonen, P. van der Heijden, A. et al.

Source: Urology. Nov2006 Supplement, Vol. 68, p298-298. 1p.

PD-11.11: Phase II marker lesion study with intravesical instillation of Eoquin^™ in superficial bladder cancer: toxicity, marker response and follow up

Authors: van der Heijden, A.G. Hendricksen, K. Cornel, E.B. et al.

Source: Urology. Nov2006 Supplement, Vol. 68, p41-41. 1p.

INTRAVESICAL PEMETREXED: POTENTIAL AND TOXICITY IN A PRE-CLINICAL PIG STUDY

Authors: Hendricksen, K. Moonen, P.M.J. Van der Heijden, A.G. et al.

Source: European Urology Supplements. Feb2006, Vol. 5 Issue 2, p188-188. 1p.

Impact of Adjuvant Radiotherapy on Survival of Patients with Pathological High-Risk Muscle Invasive Bladder Cancer: A Propensity Scored Match Paired Analysis.

Authors: Sargos, P. Zamboni, S. Hendricksen, K. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE318-E318. 1p.

Subjects: Propensity score matching, Bladder cancer, Muscles, Radiotherapy

OC-0103 Comparative study of brachytherapy vs. radical cystectomy for cT1-2 muscle-invasive bladder cancer.

Authors: Pieters, B. Voskuilen, C. Bosschieter, J. et al.

Source: Radiotherapy & Oncology. 2021 Supplement1, Vol. 158, pS70-S72. 3p.

428 SMOKING BEHAVIOUR IS A RISK FACTOR FOR RECURRENCE AFTER TRANSURETHRAL RESECTION OF NON-MUSCLE INVASIVE BLADDER CANCER

Authors: Lammers, R.J.M. Witjes, W.P.J. Hendricksen, K. et al.

Source: European Urology Supplements. Mar2011, Vol. 10 Issue 2, p147-148. 2p.

A1066 - Age represents the main driver of surgical decision making in patients candidate to radical cystectomy.

Authors: Dell'Oglio, P. Tappero, S. Panunzio, A. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1541-S1542. 2p.

A0150 - Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from a European multi-institutional collaboration (YAU Urothelial Cancer Group).

Authors: Di Trapani, E. Guzzo, S. Lievore, E. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS206-S207. 2p.

A0339 - Evaluation of the use of serum squamous cell carcinoma antigen for staging of penile cancer.

Authors: Vreeburg, M.T.A. Tomassen, Y. Kessel, R. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1146-S1146. 1p.

POD-05.07 Smoking Behaviour Is a Risk Factor for Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Authors: Lammers, R. Witjes, W. Hendricksen, K. et al.

Source: Urology. Sep2011 Supplement, Vol. 78, pS18-S18. 1p.